IMPACT OF COMPARISON H2 ANTAGONIST(H2RB) AND PROTON POMP INHIBITER (PPI)-USE IN PATIENTS TREATED WITH THIENOPYRIDINES AFTER PERCUTANEOUS CORONARY INTERVENTION (PCI) FROM CREDO KYOTO REGISTRY

Numerous studies have shown inconsistent results regarding effects of concomitant use of thienopyridines and proton pump inhibitors (PPI) on cardiovascular outcomes. We sought to evaluate clinical impact of comparison Histamine type-2 receptor antagonist and PPI-use in patients treated with